jag009
★★★

NJ,
2018-05-24 05:26
(2136 d 01:34 ago)

Posting: # 18810
Views: 2,677
 

 FDA: Biowaiver on lower strengths [Regulatives / Guidelines]

Hi guys and girls,

Question. When one does the f2 comparisons for a biowaiver on lower strengths, they are usually strength 1 vs RLD strength 2, strength 2 vs RLD strength 2, etc etc. If one passes these comparison but fails f2 for some of the lower strength vs highest strength comparison of the test products themselves, would that be an issue?

Thanks
John
wienui
★    

Germany/Oman,
2018-05-24 17:25
(2135 d 13:35 ago)

@ jag009
Posting: # 18813
Views: 2,204
 

 FDA: Biowaiver on lower strengths

Hi John,

I'm afraid yes. As the lower test strength have to pass the in vitro comparative dissolution testing vs the high bio-batch (which pass the BE study vs the RLD) test strength.
regards,
Osama

Cheers,
Osama
Yura
★    

Belarus,
2018-05-25 12:22
(2134 d 18:38 ago)

@ jag009
Posting: # 18815
Views: 2,129
 

 FDA: Biowaiver on lower strengths

Hi John,
The biowaiver for lower dosages (T1, T2) is administered with the dosage (T), which participated in the bioequivalent study.
with respect
Yura
★    

Belarus,
2018-05-26 19:21
(2133 d 11:39 ago)

@ Yura
Posting: # 18817
Views: 2,032
 

 FDA: Biowaiver on lower strengths

Hi John,
...literature, ...justification, ...comparison with the same dose of the originator, ...other statistical approaches.
with respect
UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
100 visitors (0 registered, 100 guests [including 7 identified bots]).
Forum time: 06:01 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5